Michael Mensinger
Vermogen: 2 M $ op 31-07-2026
Vermogen: 2 M $ op 31-07-2026
Mr. Michael R.
Mensinger is a Chief Product Officer at Beta Bionics, Inc. Mr. Mensinger was previously employed as a Chief Technology Officer by Companion Medical, Inc. and an Engineering Manager by DexCom, Inc. He received his undergraduate degree from the University of Delaware.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BETA BIONICS, INC. 0,41% | 02-06-2026 | 184.415 ( 0,41% ) | 2 M $ | 31-07-2026 |
BETA BIONICS, INC. -.--% | 29-01-2025 | 0 ( -.--% ) | - $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BETA BIONICS, INC. | Corporate Officer/Principal | 01-08-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Hoofd Techniek/Wetenschap/O&O | 01-08-2023 |
| DEXCOM, INC. | Corporate Officer/Principal | 01-04-2017 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Health Technology |
DexCom, Inc.
DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau